person
Manfred Paul L.
- Country
- Germany
- Department
- Internal Medicine - Gastroenterology
Research Overview
assignment
3
Clinical Trials ·
- Phase III Randomized Open-Label Study of Regorafenib and Nivolumab Versus Standard Chemotherapy in Refractory Advanced Gastro-Oesophageal Cancer
- Phase III Trial on Disease-Free Survival in Resected Pancreatic Ductal Adenocarcinoma Using Oxaliplatin or Gemcitabine-Based Chemotherapy Allocation by Transcriptomic Signature
- Phase 2 Study of DKN-01 and Tislelizumab ± Chemotherapy in Inoperable Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
location_city
1
Research Sites
Data & Insights
medical_services
Primary Speciality
Main therapeutic area
handshake
Return Partnerships
Recurring site collaborations
10
Sites with multiple studies
Has run more than one trial at 10 of 55 partner sites.
Specializations
Breast Cancer Research
Specializes in investigating therapeutic approaches for triple negative breast cancer (TNBC), with particular focus on neoadjuvant and adjuvant treatment combinations.
- Advanced TNBC Management
- Combined Therapy Approaches
Gastrointestinal Oncology
Conducts research in advanced gastro-esophageal cancers and gastric adenocarcinoma, exploring innovative treatment strategies and combinations.
- Metastatic Gastric Cancer
- Gastroesophageal Junction Tumors
- Advanced GI Malignancies
Colorectal Cancer Studies
Focuses on treatment approaches for locally advanced rectal cancer, investigating both surgical and non-surgical therapeutic strategies.
- Organ Preservation Techniques
- Multimodal Treatment Approaches
- Risk-Adapted Therapies
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.